Translational Product Development Fund (TPDF)

Mayo Clinic Center for Clinical and Translational Science (CCaTS) and the University of Minnesota Clinical and Translational Science Institute, in conjunction with the Minnesota Partnership for Biotechnology and Medical Genomics, have established the Translational Product Development Fund (TPDF).

The goal of the TPDF is to provide support to University of Minnesota and Mayo Clinic investigators to advance projects that have the potential to be commercialized, such as projects to form start-up companies or license agreements with established commercial entities.

More information about the TPDF is available on the University of Minnesota website.


Roberto Zayas, Ph.D., J.D.